Ikarian Capital, LLC Solid Biosciences Inc. Transaction History

Ikarian Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.43 - $1.24 $224,096 - $646,232	-521,155 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.38 - $3.77 $367,757 - $582,540	-154,520 Reduced 22.87%	521,155 $1.25 Million
Q2 2021 Aug 16, 2021	BUY	$3.49 - $5.51 $2.28 Million - $3.59 Million	652,058 Added 2760.97%	675,675 $2.47 Million
Q1 2021 May 17, 2021	SELL	$5.37 - $10.72 $4.1 Million - $8.19 Million	-764,391 Reduced 97.0%	23,617 $131,000
Q2 2020 Aug 14, 2020	BUY	$2.1 - $3.42 $522,805 - $851,426	248,955 Added 46.18%	788,008 $2.31 Million
Q1 2020 May 15, 2020	BUY	$2.31 - $4.43 $1.25 Million - $2.39 Million	539,053 New	539,053 $1.29 Million

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $31M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.